William H. Carson

Insider Reports History

Entity
Individual
Location
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 1520, New York, NY
Signature
/s/ Jennifer Lew, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William H. Carson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Annexon, Inc. Director Common Stock 22.4K $134K $5.97 Oct 1, 2024 Direct
Annexon, Inc. Director Stock Option (Right to Buy) 44K Jun 5, 2024 Direct
Decibel Therapeutics, Inc. Director Common Stock 0 $5.03 Sep 25, 2023 Direct
Decibel Therapeutics, Inc. Director Stock Option (right to buy) 0 Sep 25, 2023 Direct

Insider Reports Filed by William H. Carson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANNX Annexon, Inc. Oct 1, 2024 1 $19.1K 4 Oct 2, 2024 Director
ANNX Annexon, Inc. Sep 3, 2024 1 $17.5K 4 Sep 4, 2024 Director
ANNX Annexon, Inc. Aug 1, 2024 1 $20K 4 Aug 5, 2024 Director
ANNX Annexon, Inc. Jul 1, 2024 1 $16K 4 Jul 2, 2024 Director
ANNX Annexon, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
ANNX Annexon, Inc. Jun 3, 2024 1 $15.5K 4 Jun 5, 2024 Director
ANNX Annexon, Inc. May 1, 2024 1 $15K 4 May 3, 2024 Director
ANNX Annexon, Inc. Apr 8, 2024 1 $19.4K 4 Apr 10, 2024 Director
DBTX Decibel Therapeutics, Inc. Sep 25, 2023 4 $0 4 Sep 25, 2023 Director
DBTX Decibel Therapeutics, Inc. Jun 13, 2023 2 $0 4 Jun 14, 2023 Director
ANNX Annexon, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
DBTX Decibel Therapeutics, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
ANNX Annexon, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
ANNX Annexon, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
DBTX Decibel Therapeutics, Inc. Jun 2, 2021 1 $0 4 Jun 3, 2021 Director
DBTX Decibel Therapeutics, Inc. Jun 2, 2021 0 $0 3 Jun 3, 2021 Director